Work

Abstract 3024: The novel selective CDK9 Inhibitor ORI-15412 reduces PD-L1 expression and drives the efficacy in combination therapies for melanoma and triple-negative breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3024

Authors: Gergana Galabova, Michael Almstetter, Nicole Brusis, Christiane Gilch, Roland Koestler, Julie Kondrotas, Jan Kubitzki, Henrik Kuhn, Hendrik Liebers, Federico Medda, Patricia Perez-Galan, Jean Tassel, Nadine Traube, Andreas Treml, David Wifling, Nasser Yehia, Peter Zegar, Michael Thormann

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409629690

Cites:

Cited by:

Related to: 10